New 10% holder at Tenax Therapeutics (TENX) wields $0.01 warrants
Rhea-AI Filing Summary
TENAX THERAPEUTICS, INC. (TENX) has a new initial ownership report from ADAR1 Capital Management, LLC and Daniel Schneeberger as ten percent owners under Section 16. Private investment funds managed by ADAR1 hold 3,827,951 shares of common stock indirectly, plus derivative securities.
The funds also hold Pre-Funded Warrants exercisable for 59,073 shares of common stock at an exercise price of $0.01 per share, with no expiration, and Warrants exercisable for 31,096 shares at $4.50 per share, exercisable until the earlier of September 22, 2026 or exercise of the Pre-Funded Warrants. Both warrant types include a 4.99% beneficial ownership cap. Each reporting person disclaims beneficial ownership beyond any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Pre-Funded Warrant F3, F1, F2 | -- | -- | -- |
| holding | Warrant F4, F1, F2 | -- | -- | -- |
| holding | Common Stock F1, F2 | -- | -- | -- |
Footnotes (4)
- F1. The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.
- F2. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
- F3. The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time on or after the date of issuance. A holder of the Pre-Funded Warrants may not exercise the Pre-Funded Warrants if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
- F4. The warrants to purchase shares of the Issuer's common stock (the "Warrants") are exercisable at any time on or after the date of issuance and before the earlier of (i) September 22, 2026, and (ii) the exercise of the Pre-Funded Warrants. A holder of the Warrants may not exercise the Warrants if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Key Figures
Key Terms
Pre-Funded Warrants financial
beneficial ownership financial
pecuniary interest financial
Section 16 of the Securities Exchange Act of 1934 regulatory
beneficial ownership limitation financial
FAQ
What does Form 3 report for TENX regarding ADAR1 Capital Management and Daniel Schneeberger?
What standard Warrants for TENX are disclosed and when do they expire?
What is the 4.99% beneficial ownership limitation mentioned for TENX warrants?
Do the TENX reporting persons claim full beneficial ownership of the reported securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.